Antigenicity of Clostridium botulinum type-E formol toxoid.
D000818:Animals; D000937:Antigen-Antibody Reactions; D000941:Antigens / Q000032:analysis*; D000992:Antitoxins; D001905:Botulinum Toxins; D002417:Cattle; D002850:Chromatography, Gel; D002986:Clinical Trials as Topic; D003014:Clostridium botulinum / Q000276:immunology*; D005557:Formaldehyde; D006168:Guinea Pigs; D006801:Humans; D007114:Immunization; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D051379:Mice; D009584:Nitrogen / Q000032:analysis; D011506:Proteins / Q000032:analysis; D011817:Rabbits; D013997:Time Factors; D014121:Toxoids / Q000032:analysis; D014357:Trypsin; D014461:Ultracentrifugation
D000941:Antigens; D000992:Antitoxins; D011506:Proteins; D014121:Toxoids; D005557:Formaldehyde; D014357:Trypsin; D001905:Botulinum Toxins; D009584:Nitrogen